Provides therapeutic, diagnostic product development and medical research services
Sector:
Health Technology
Industry:
Biotechnology
Employees:
Frequently Asked Questions
What is Market Cap of Rosetta Genomics Ltd?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Rosetta Genomics Ltd market cap is $36,200.00.
What is the 52-week high for Rosetta Genomics Ltd?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rosetta Genomics Ltd 52 week high is $1.68 as of October 04, 2025.
What is the 52-week low for Rosetta Genomics Ltd?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rosetta Genomics Ltd 52 week low is $0.0001 as of October 04, 2025.
What is Rosetta Genomics Ltd stock price today?
Rosetta Genomics Ltd stock price today is $0.0061.
What was Rosetta Genomics Ltd stock price yesterday?
Rosetta Genomics Ltd stock price yesterday was $0.0122.
What is the PE ratio of Rosetta Genomics Ltd?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Rosetta Genomics Ltd’s P/E ratio is None.
What is the Price-to-Book ratio of Rosetta Genomics Ltd?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Rosetta Genomics Ltd P/B ratio is 0.0330.
What is Rosetta Genomics Ltd's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Rosetta Genomics Ltd's EBITDA is N/A.
What is the 50-day moving average of Rosetta Genomics Ltd?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Rosetta Genomics Ltd 50-day moving average is $0.0171.
